| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $55.8M | +12.6% |
| R&D Expense | $53.2M | -30.9% |
| SG&A Expense | $47.0M | -5.9% |
| Operating Income | -$79.2M | +27.3% |
| Income Tax | $0 | — |
| Net Income | -$49.0M | +64.5% |
| EPS (Basic) | -$22.27 | -3081.4% |
| EPS (Diluted) | -$22.27 | -3081.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $13.2M | -69.7% |
| Accounts Receivable | $9.5M | +0.8% |
| Inventory | $684K | -68.3% |
| Current Assets | $39.7M | -60.0% |
| Total Assets | $100.2M | -42.6% |
| Current Liabilities | $27.7M | -8.9% |
| Total Liabilities | $90.9M | -43.6% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$64.9M | +27.2% |
| Capital Expenditures | $1.3M | -76.3% |
| Investing Cash Flow | $11.2M | -60.7% |
| Financing Cash Flow | $25.6M | -15.2% |
| Free Cash Flow | -$66.1M | +29.9% |
| -$3.9M |
| -128.9% |